GlassScriptPhysician profile
Scotlyn Patterson
NPI 1740891357
$1,795.92
in general payments reported to CMS, 2019-2025
16 companies · $685 in 2025
The $685 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $384 · 2023: $161 · 2024: $567 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $255.09 | 2022-2025 | Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.54 | 2022-2025 | Relistor |
| Forte Bio-Pharma LLC | $223.80 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Averitas Pharma INC. | $198.50 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $189.17 | 2024-2025 | Belbuca |
| Abbvie INC. | $149.53 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $130.82 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $123.52 | 2023 | Quviviq |
| Convatec INC. | $94.30 | 2022 | |
| Nevro Corp. | $46.64 | 2022-2024 | Senza |
| Spr Therapeutics, INC | $34.10 | 2024-2025 | Sprint Pns System |
| Valinor Pharma, LLC | $31.28 | 2025 | Movantik |
| Boston Scientific Corporation | $23.13 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.99 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.28 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15.23 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scotlyn Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.